|
1
|
Samadi S, Bozorgmanesh M, Khalili D,
Momenan A, Sheikholeslami F, Azizi F and Hadaegh F:
Hypertriglyceridemic waist: The point of divergence for prediction
of CVD vs. mortality: Tehran Lipid and Glucose Study. Int J
Cardiol. 165:260–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong MC, Zhang DX and Wang HH: Rapid
emergence of atherosclerosis in Asia: A systematic review of
coronary atherosclerotic heart disease epidemiology and
implications for prevention and control strategies. Curr Opin
Lipidol. 26:257–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gkaliagkousi E, Gavriilaki E,
Triantafyllou A and Douma S: Clinical significance of endothelial
dysfunction in essential hypertension. Curr Hypertens Rep.
17:852015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lucia J, Lucia M, Lucia J, Janicko M,
Fedacko J, Novakova B, Chmelarova A, Majernik J and Pella D: Effect
of ivabradine on endothelial function in patients with stable
angina pectoris: Assessment with the Endo-PAT 2000 device. Adv
Ther. 32:962–970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shaw J and Anderson T: Coronary
endothelial dysfunction in non-obstructive coronary artery disease:
Risk, pathogenesis, diagnosis and therapy. Vasc Med. 21:146–155.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gu X, Yang X, Li Y, Cao J, Li J, Liu X,
Chen J, Shen C, Yu L, Huang J and Gu D: Usefulness of low-density
lipoprotein cholesterol and non-high-density lipoprotein
cholesterol as predictors of cardiovascular disease in Chinese. Am
J Cardiol. 116:1063–1070. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuhlencordt PJ, Padmapriya P, Rützel S,
Schödel J, Hu K, Schäfer A, Huang PL, Ertl G and Bauersachs J:
Ezetimibe potently reduces vascular inflammation and
arteriosclerosis in eNOS-deficient ApoE ko mice. Atherosclerosis.
202:48–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li H, Horke S and Förstermann U: Vascular
oxidative stress, nitric oxide and atherosclerosis.
Atherosclerosis. 237:208–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frostegård J: Immunity, atherosclerosis
and cardiovascular disease. BMC Med. 11:1172013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Diepen JA, Berbée JF, Havekes LM and
Rensen PC: Interactions between inflammation and lipid metabolism:
Relevance for efficacy of anti-inflammatory drugs in the treatment
of atherosclerosis. Atherosclerosis. 228:306–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mitra S, Khaidakov M, Lu J, Ayyadevara S,
Szwedo J, Wang XW, Chen C, Khaidakov S, Kasula SR, Stone A, et al:
Prior exposure to oxidized low-density lipoprotein limits apoptosis
in subsequent generations of endothelial cells by altering promoter
methylation. Am J Physiol Heart Circ Physiol. 301:H506–H513. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abeyrathna P and Su Y: The critical role
of Akt in cardiovascular function. Vascul Pharmacol. 74:38–48.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu H, Littlewood T and Bennett M: Akt
isoforms in vascular disease. Vascul Pharmacol. 71:57–64. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jones SP, Gibson MF, Rimmer DM III, Gibson
TM, Sharp BR and Lefer DJ: Direct vascular and cardioprotective
effects of rosuvastatin, a new HMG-CoA reductase inhibitor. J Am
Coll Cardiol. 40:1172–1178. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Wang SJ, Han ZH, Li YQ, Xue JH,
Gao DF, Wu XS and Wang CX: PI3K/AKT signaling pathway plays a role
in enhancement of eNOS activity by recombinant human angiotensin
converting enzyme 2 in human umbilical vein endothelial cells. Int
J Clin Exp Pathol. 7:8112–8117. 2014.PubMed/NCBI
|
|
16
|
Aggarwal RK and Showkathali R:
Rosuvastatin calcium in acute coronary syndromes. Expert Opin
Pharmacother. 14:1215–1227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qian C, Wei B, Ding J, Wu H, Cai X, Li B
and Wang Y: Meta-analysis comparing the effects of rosuvastatin
versus atorvastatin on regression of coronary atherosclerotic
plaques. Am J Cardiol. 116:1521–1526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takayama T, Komatsu S, Ueda Y, Fukushima
S, Hiro T, Hirayama A and Saito S: ALTAIR study group: Comparison
of the effect of rosuvastatin 2.5 mg vs. 20 mg on coronary plaque
determined by angioscopy and intravascular ultrasound in Japanese
with stable angina pectoris (from the Aggressive Lipid-Lowering
Treatment Approach Using Intensive Rosuvastatin for Vulnerable
Coronary Artery Plaque [ALTAIR] Randomized Trial). Am J Cardiol.
117:1206–1212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kurtoglu E, Balta S, Sincer I, Altas Y,
Atas H, Yilmaz M, Korkmaz H, Erdem K, Akturk E, Demirkol S and Can
C: Comparision of effects of rosuvastatin versus atorvastatin
treatment on plasma levels of asymmetric dimethylarginine in
patients with hyperlipidemia having coronary artery disease.
Angiology. 65:788–793. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Castellon X and Bogdanova V: Chronic
inflammatory diseases and endothelial dysfunction. Aging Dis.
7:81–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Byfield FJ, Rothblat GH, Gooch KJ and
Levitan I: OxLDL increases endothelial stiffness, force generation
and network formation. Vascul Pharmacol. 45:e732006. View Article : Google Scholar
|
|
22
|
Ananthakrishnan S and Kaysen GA: Treatment
of hyperlipidemia changes with level of kidney function-rationale.
Adv Chronic Kidney Dis. 23:247–254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xing Y, Lai J, Liu X, Zhang N, Ming J, Liu
H and Zhang X: Netrin-1 restores cell injury and impaired
angiogenesis in vascular endothelial cells upon high glucose by
PI3K/AKT-eNOS. J Mol Endocrinol. 58:167–177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haendeler J, Weiland U, Zeiher AM and
Dimmeler S: Effects of redox-related congeners of NO on apoptosis
and caspase-3 activity. Nitric Oxide. 1:282–293. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Frank S, Kämpfer H, Wetzler C and
Pfeilschifter J: Nitric oxide drives skin repair: Novel functions
of an established mediator. Kidney Int. 61:882–888. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vulesevic B, McNeill B, Giacco F, Maeda K,
Blackburn NJ, Brownlee M, Milne RW and Suuronen EJ:
Methylglyoxal-induced endothelial cell loss and inflammation
contribute to the development of diabetic cardiomyopathy. Diabetes.
65:1699–1713. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Ma KL, Liu J, Wu Y, Hu ZB, Liu L,
Lu J, Zhang XL and Liu BC: Inflammatory stress exacerbates lipid
accumulation and podocyte injuries in diabetic nephropathy. Acta
Diabetol. 52:1045–1056. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Konishi H, Miyauchi K, Shitara J, Endo H,
Wada H, Doi S, Naito R, Tsuboi S, Ogita M, Dohi T, et al: Impact of
lipoprotein(a) on long-term outcomes in patients with diabetes
mellitus who underwent percutaneous coronary intervention. Am J
Cardiol. 118:1781–1785. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang X, Li Y, Li Y, Ren X, Zhang X, Hu D,
Gao Y, Xing Y and Shang H: Oxidative stress-mediated
atherosclerosis: Mechanisms and therapies. Front Physiol.
8:6002017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Desjardins F and Balligand JL: Nitric
oxide-dependent endothelial function and cardiovascular disease.
Acta Clin Belg. 61:326–334. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo J, Breen DM, Pereira TJ, Dalvi PS,
Zhang H, Mori Y, Ghanim H, Tumiati L, Fantus IG, Bendeck MP, et al:
The effect of insulin to decrease neointimal growth after arterial
injury is endothelial nitric oxide synthase-dependent.
Atherosclerosis. 241:111–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahsan A, Han G, Pan J, Liu S, Padhiar AA,
Chu P, Sun Z, Zhang Z, Sun B, Wu J, et al: Phosphocreatine protects
endothelial cells from oxidized low-density lipoprotein-induced
apoptosis by modulating the PI3K/Akt/eNOS pathway. Apoptosis.
20:1563–1576. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Valentino M, Al Danaf J, Panakos A,
Ragupathi L, Duffy D and Whellan D: Impact of the 2013 American
College of Cardiology/American Heart Association cholesterol
guidelines on the prescription of high-intensity statins in
patients hospitalized for acute coronary syndrome or stroke. Am
Heart J. 181:130–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
O'Keefe JH, DiNicolantonio JJ and Lavie
CJ: Statins, ezetimibe, and proprotein convertase subtilisin-kexin
Type 9 inhibitors to reduce low-density lipoprotein cholesterol and
cardiovascular events. Am J Cardiol. 119:565–571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong Y, Fernandes C, Liu Y, Wu Y, Wu H,
Brophy ML, Deng L, Song K, Wen A, Wong S, et al: Role of
endoplasmic reticulum stress signalling in diabetic endothelial
dysfunction and atherosclerosis. Diab Vasc Dis Res. 14:14–23. 2017.
View Article : Google Scholar : PubMed/NCBI
|
